The Potential Use of Cannabis in Tissue Fibrosis


Nazar Pryimak, Mariia Zaiachuk, Olga Kovalchuk, and Igor Kovalchuk

Published in Frontiers in Cell and Developmental Biology

October 2021



Fibrosis is a condition characterized by thickening or/and scarring of various tissues. Fibrosis may develop in almost all tissues and organs, and it may be one of the leading causes of morbidity and mortality. It provokes excessive scarring that excels the usual wound healing response to trauma in numerous organs. Currently, very little can be done to prevent tissue fibrosis, and it is almost impossible to reverse it. Anti-inflammatory and immunosuppressive drugs are among the few treatments that may be efficient in preventing fibrosis. Numerous publications suggest that cannabinoids and extracts of Cannabis sativa have potent anti-inflammatory and anti-fibrogenic properties. In this review, we describe the types and mechanisms of fibrosis in various tissues and discuss various strategies for prevention and dealing with tissue fibrosis. We further introduce cannabinoids and their potential for the prevention and treatment of fibrosis, and therefore for extending healthy lifespan.

Full Paper>>

DOI: 10.3389/fcell.2021.715380



Pryimak, N., Zaiachuk, M., Kovalchuk, O., & Kovalchuk, I. (2021). The Potential Use of Cannabis in Tissue Fibrosis. Frontiers in Cell and Developmental Biology, 9.